Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 14;7(4):1168-1181.
doi: 10.4338/ACI-2016-09-RA-0160.

ePrescribing: Reducing Costs through In-Class Therapeutic Interchange

Shane P Stenner, Rohini Chakravarthy, Kevin B Johnson, William L Miller, Julie Olson, Marleen Wickizer, Nate N Johnson, Rick Ohmer, David R Uskavitch, Gordon R Bernard, Erin B Neal, Christoph U Lehmann  1
Affiliations

ePrescribing: Reducing Costs through In-Class Therapeutic Interchange

Shane P Stenner et al. Appl Clin Inform. .

Abstract

Introduction: Spending on pharmaceuticals in the US reached $373.9 billion in 2014. Therapeutic interchange offers potential medication cost savings by replacing a prescribed drug for an equally efficacious therapeutic alternative.

Methods: Hard-stop therapeutic interchange recommendation alerts were developed for four medication classes (HMG-CoA reductase inhibitors, serotonin receptor agonists, intranasal steroid sprays, and proton-pump inhibitors) in an electronic prescription-writing tool for outpatient prescriptions. Using prescription data from January 2012 to June 2015, the Compliance Ratio (CR) was calculated by dividing the number of prescriptions with recommended therapeutic interchange medications by the number of prescriptions with non-recommended medications to measure effectiveness. To explore potential cost savings, prescription data and medication costs were analyzed for the 45,000 Vanderbilt Employee Health Plan members.

Results: For all medication classes, significant improvements were demonstrated - the CR improved (proton-pump inhibitors 2.8 to 5.32, nasal steroids 2.44 to 8.16, statins 2.06 to 5.51, and serotonin receptor agonists 0.8 to 1.52). Quarterly savings through the four therapeutic interchange interventions combined exceeded $200,000 with an estimated annual savings for the health plan of $800,000, or more than $17 per member.

Conclusion: A therapeutic interchange clinical decision support tool at the point of prescribing resulted in increased compliance with recommendations for outpatient prescriptions while producing substantial cost savings to the Vanderbilt Employee Health Plan - $17.77 per member per year. Therapeutic interchange rules require rational targeting, appropriate governance, and vigilant content updates.

Keywords: Therapeutic interchange; cost savings; electronic health record; electronic prescribing.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Centralized CDS model for RxStar (DSS = Decision Support System)
Fig. 2
Fig. 2
Example of a therapeutic interchange alert
Fig. 3
Fig. 3
Interchange medication prescriptions
Fig. 4
Fig. 4
Cost per member per quarter based on therapeutic class
See this image and copyright information in PMC

References

    1. Centers for Medicare and Medicaid Services. National Health Expenditures 2012 Highlights. Available online at https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Tren.... Last accessed May 10, 2015.
    1. Centers for Medicare and Medicaid Services. National Health Expenditures 2013 Highlights. Available online at http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trend... Last accessed May 10, 2015.
    1. IMS Institute for Healthcare Informatics. Medicines Use and Spending Shifts: A Review of the Use of Medicines in the U.S. in 2014. Available online at http://www.redaccionmedica.com/contenido/images/IIHI_Use_of_Medicines_Re.... Last accessed May 14, 2015.
    1. Lorenzetti L. The U.S. Has the Highest Drug Prices in the World. And Hating Martin Shkreli Won‘t Be Enough to Change It. Fortune 2015; 172(6): 17-18. PubMed PMID: 26875209. - PubMed
    1. Daemmrich A, Mohanty A. Healthcare reform in the United States and China: pharmaceutical market implications. J Pharm Policy Pract 2014; 7(1): 9. doi: 10.1186/2052–3211–7–9. eCollection 2014. PubMed PMID: 25097759; PubMed Central PMCID: PMC4117976. - PMC - PubMed

MeSH terms